With several drugs in use that inhibit the hepatitis B virus polymerases (nucleos(t)ide analogues (or NUCs)), some argue that new direct-acting antiviral drugs, and new NUCs in particular ...

Single-dose administration of E6F6 could profoundly suppress the levels of hepatitis B surface antigen (HBsAg ... E6F6 recognises an evolutionarily conserved epitope (GPCK(R)TCT) and only forms a ...

in particular hepatitis B surface-specific T cell responses. HBV-specific CD8 + T cells with different target specificities (HBV core epitope vs HBV polymerase (pol) epitope) are characterised by ...

Study: AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in ... or HBV core antibody (anti-HBc). The most common cause of HBVr is prolonged ...

Hepatitis B (sometimes referred to as hep B) is a liver infection caused by the hepatitis B virus (HBV). It typically causes symptoms like stomach pain, dark urine, fatigue, fever, jaundice (yellowing ...